Patients with T2D often have comorbid conditions such as hypertension, dyslipidemia, and obesity, which further exacerbate the risk of developing atherosclerotic cardiovascular disease (ASCVD).The management of these patients often involves percutaneous coronary intervention (PCI)with stent implantation 1
According to analyst commentary, an Eli Lilly NDA filing could come in Q4 2026 at the earliest
Figuring out whether Ozempic causes hair loss involves examining how shifts in weight, metabolism, hormones, and nutrition impact the hair growth cycle
Its broad range of effects suggests potential applications for tissue regeneration, gut health, neurological conditions, cardiovascular protection, and chronic pain management
Australias medicines regulator has issued warnings for several type 2 diabetes and obesity-related treatments including Ozempic and Mounjaro over the potential to cause a rare but severe eye disorder that could lead to blindness
Similar efficacy and gastrointestinal tolerability versus exposure for oral and subcutaneous semaglutide